| scholarly article | Q13442814 |
| P356 | DOI | 10.18632/ONCOTARGET.23276 |
| P8608 | Fatcat ID | release_s6odpdjk6fd3bgv4hf66tjdq24 |
| P932 | PMC publication ID | 5787452 |
| P698 | PubMed publication ID | 29416707 |
| P50 | author | Liren Qian | Q82473521 |
| Lajos Raduly | Q86811762 | ||
| Ioana Berindan-Neagoe | Q87613611 | ||
| Jianliang Shen | Q87726325 | ||
| Alexandru Irimie | Q92061610 | ||
| Alina D Tanase | Q98173300 | ||
| Ancuța Jurj | Q108750495 | ||
| Ioana Rus | Q108916485 | ||
| Delia Dima | Q108916487 | ||
| Bobe Petrushev | Q114428590 | ||
| Ciprian Ionuţ Tomuleasa | Q41181584 | ||
| Cristian Berce | Q42424487 | ||
| P2093 | author name string | Yi Liu | |
| Yu Liu | |||
| P2860 | cites work | Early expression of plasma CCL8 closely correlates with survival rate of acute graft-vs.-host disease in mice | Q84587185 |
| MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease | Q87134152 | ||
| Urinary proteomics employing capillary electrophoresis coupled to mass spectrometry in the monitoring of patients after stem cell transplantation | Q87184029 | ||
| The importance of microRNAs in the stroma-breast cancer cell interplay | Q87986758 | ||
| Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 | ||
| Rab27a and Rab27b control different steps of the exosome secretion pathway | Q24336455 | ||
| Acute lymphoblastic leukaemia | Q24602387 | ||
| MiR-15a and miR-16-1 cluster functions in human leukemia | Q24647555 | ||
| B lymphocytes secrete antigen-presenting vesicles | Q24678522 | ||
| HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation | Q27022939 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| ExoCarta: A compendium of exosomal proteins and RNA | Q28260686 | ||
| Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury | Q28272621 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Isolation and characterization of exosomes from cell culture supernatants and biological fluids | Q29615035 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| miRNAs, cancer, and stem cell division | Q29618925 | ||
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
| Functional delivery of viral miRNAs via exosomes | Q29619574 | ||
| Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis | Q30585821 | ||
| Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. | Q30805170 | ||
| Nanopharmacology in translational hematology and oncology | Q33961538 | ||
| Pathogenesis and management of graft-versus-host disease. | Q34077479 | ||
| Allogeneic hematopoietic cell transplantation: the state of the art | Q34145155 | ||
| Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children | Q34148885 | ||
| Acute myeloid leukaemia in adults | Q34327218 | ||
| Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease | Q34408137 | ||
| Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance | Q34530668 | ||
| Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels | Q34624143 | ||
| Exosomes as divine messengers: are they the Hermes of modern molecular oncology? | Q34675263 | ||
| A systematic review of dental late effects in survivors of childhood cancer | Q34802494 | ||
| Highlights of a new type of intercellular communication: microvesicle-based information transfer. | Q34918377 | ||
| Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. | Q35007600 | ||
| HLA Typing for the Next Generation | Q35643999 | ||
| Human tumor-derived exosomes down-modulate NKG2D expression. | Q39980589 | ||
| Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer | Q40178075 | ||
| Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients? | Q40189189 | ||
| The regulation of exosome secretion: a novel function of the p53 protein | Q40284999 | ||
| Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. | Q40452110 | ||
| Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. | Q40458863 | ||
| The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation | Q40591704 | ||
| Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides | Q40634671 | ||
| Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation. | Q40787485 | ||
| Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface | Q40867441 | ||
| Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report | Q41417888 | ||
| Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation | Q41549282 | ||
| Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis | Q42626003 | ||
| Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study | Q43640569 | ||
| MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. | Q43645305 | ||
| Stability of endogenous and added RNA in blood specimens, serum, and plasma | Q44153103 | ||
| Monitoring of TNFR1, IL-2Rα, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in paediatric patients. | Q45896729 | ||
| Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. | Q45946092 | ||
| Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy | Q46059376 | ||
| Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? | Q46390583 | ||
| LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity | Q47654313 | ||
| Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. | Q55052874 | ||
| Induction of Tolerance by Exosomes and Short-Term Immunosuppression in a Fully MHC-Mismatched Rat Cardiac Allograft Model | Q58862017 | ||
| Shedding from normal and cancer-cell surfaces | Q67237169 | ||
| Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q79880337 | ||
| Metabolism and therapeutic angiogenesis | Q81399365 | ||
| Tumor angiogenesis | Q81784542 | ||
| Two Rabs for exosome release | Q82309803 | ||
| Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma | Q35742379 | ||
| How I treat refractory acute GVHD. | Q35828633 | ||
| Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages | Q35831305 | ||
| The involvement of endothelial progenitor cells in tumor angiogenesis. | Q35921533 | ||
| Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review | Q35953264 | ||
| Advances in understanding the pathogenesis of graft-versus-host disease | Q35971439 | ||
| Long non-coding RNAs and cancer: a new frontier of translational research? | Q36208103 | ||
| MicroRNAs and chromosomal abnormalities in cancer cells | Q36617820 | ||
| Genetics of graft-versus-host disease: the major histocompatibility complex | Q36766250 | ||
| Advances in the treatment of acute graft-versus-host disease. | Q37191057 | ||
| Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. | Q37275902 | ||
| Role of HLA in hematopoietic SCT. | Q37315413 | ||
| IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease. | Q37661441 | ||
| Circulating tumor cells: a window into cancer biology and metastasis | Q37673460 | ||
| Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages | Q37852227 | ||
| Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)? | Q37948976 | ||
| Extracellular vesicles--vehicles that spread cancer genes | Q37996375 | ||
| Potential biomarkers for early detection of acute graft-versus-host disease | Q38038568 | ||
| On the role of HLA antibodies in hematopoietic stem cell transplantation | Q38065269 | ||
| Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies | Q38079449 | ||
| Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies | Q38095833 | ||
| Inflammatory markers in patients after hematopoietic stem cell transplantation | Q38096877 | ||
| Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies | Q38098957 | ||
| Biologic markers of chronic GVHD. | Q38123020 | ||
| Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how. | Q38130168 | ||
| An update on pulmonary complications of hematopoietic stem cell transplantation | Q38168100 | ||
| Experts' considerations on HLA-haploidentical stem cell transplantation | Q38198728 | ||
| Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma | Q38207013 | ||
| Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions | Q38207595 | ||
| Next generation treatment of acute graft-versus-host disease | Q38221028 | ||
| Cancer stem-like cells: the dark knights of clinical hematology and oncology | Q38223261 | ||
| MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation | Q38434710 | ||
| Mesenchymal stromal cells with enhanced therapeutic properties | Q39045625 | ||
| Proteomic analysis of exosome-like vesicles derived from breast cancer cells | Q39383521 | ||
| The regulation of the endosomal compartment by p53 the tumor suppressor gene | Q39870361 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1483-1491 | |
| P577 | publication date | 2017-12-15 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Protein dysregulation in graft versus host disease | |
| P478 | volume | 9 |
| Q92941857 | Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician |
| Q90267017 | LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society f |
Search more.